EU clamps down on reimportation of cheap drugs meant for AfricaBMJ 2002; 325 doi: https://doi.org/10.1136/bmj.325.7372.1058 (Published 09 November 2002) Cite this as: BMJ 2002;325:1058
- Rory Watson
The European Union is taking measures to prevent low cost drugs intended for patients in some of the world's poorest countries from being diverted and resold for huge profits in the West.
By clamping down on the illegal trade in reimported drugs that undercuts standard European prices, the EU is hoping to encourage pharmaceutical companies to expand the trend of making medicines available at special rates to the developing world.
The initiative comes amid growing evidence that cut price drugs are being diverted onto …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial